José María Mato de la Paz
Founder at One Way Liver SL
Network origin in José María Mato de la Paz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
One Way Liver SL
 One Way Liver SL Miscellaneous Commercial ServicesCommercial Services One Way Liver SL designs and develops diagnostic solutions for liver conditions. It designs and develops of non-invasive diagnostic solutions for hepatic conditions, such as fatty liver disease and non-alcoholic steatohepatitis. The firm also provides research and clinical testing services to clients in the pharmaceutical and biomedical product industries. The company was founded by José Maria Mato de la Paz in 2002 and is headquartered in Derio, Spain.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Atlas Molecular Pharma SL
 Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Atlas Molecular Pharma SL engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases. The company was founded in September 2015 and is headquartered in Derio, Spain.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to José María Mato de la Paz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Inter-American Development Bank
 Inter-American Development Bank SupranationalGovernment Inter-American Development Bank engages in the provision of development financing to the Latin American and the Caribbean region. Its activities include provision of loans, grants, and technical assistance; and conducts extensive research. It provides services to the central governments, provinces, municipalities, private firms, and non-governmental organizations. The company was founded in 1959 and is headquartered in Washington, DC. | Supranational | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
| LABORATORIOS FARMACEUTICOS ROVI, S.A. | Pharmaceuticals: Major | Director/Board Member | |
| Universidad Complutense de Madrid | College/University | Graduate Degree | |
| University of Barcelona | College/University | Graduate Degree | |
| University of Deusto | College/University | Undergraduate Degree | |
| The University of the Basque Country | College/University | Doctorate Degree | |
| Universidad Politécnica de Madrid | College/University | Undergraduate Degree | |
| Universitat Pompeu Fabra | College/University | Corporate Officer/Principal | |
| Medical College of Virginia | College/University | Corporate Officer/Principal | |
| National Institute of Diabetes & Digestive & Kidney Diseases | General Government | Corporate Officer/Principal | |
Venter Pharma SL
 Venter Pharma SL Pharmaceuticals: MajorHealth Technology Venter Pharma SL develops and manufactures pharmaceutical products. The firm’s products include lactest and xylossay. The company was founded by Juan Jose Aragon Reyes and Alfonso Fernandez Alvarez Mayoralas in 2003 and is headquartered in Alcobendas, Spain. | Pharmaceuticals: Major | Chairman | |
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Investment Managers | Founder Private Equity Investor | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree Graduate Degree | |
Inveready Asset Management SGEIC SA
 Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Investment Managers | Private Equity Investor | |
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Medical Specialties | Director/Board Member Director/Board Member | |
| Servizo Galego de Saúde CGA (Spain) | Chief Executive Officer | ||
| Lilly SA | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Spain Ministry of Health, Social Services & Equality | General Government | Corporate Officer/Principal | |
| Johnson Wax Espanola SA | Chief Operating Officer | ||
| University of Lleida | College/University | Undergraduate Degree | |
Health In Code SL
 Health In Code SL Medical/Nursing ServicesHealth Services Health in Code SL specializes in the genetic diagnosis of cardiovascular diseases. The firm provides gene panel testing and interpretation services for a variety of cardiopathies, including pulmonary hypertension, hypercholesterolemia and ventricular tachycardia. Its services include Medical Genetics, Laboratory Management System, HiC-Mutations and Laboratory Services. The company was founded by Lorenzo Jose Montserrat on June 23, 2006 and is headquartered in A Coruna, Spain. | Medical/Nursing Services | Chairman Director/Board Member | |
Bionanoplus SL
 Bionanoplus SL BiotechnologyHealth Technology Bionanoplus SL designs and develops drug delivery systems. It specializes in providing polymeric nanoencapsulation solutions. The firm's services include design, optimization, and characterization of polymeric particulate systems, analysis and quality control parameters control, in vivo evaluation and scale-up. The company was founded by Hesham Hamdi Salman in 2010 and is headquartered in Noain, Spain. | Biotechnology | Director/Board Member | |
Smart Solutions Technologies SL
 Smart Solutions Technologies SL Medical SpecialtiesHealth Technology Smart Solutions Technologies SL engages in the design, development, and manufacture of wireless medical devices. It offers fabric-integrated wearable electrocardiograph sensors and proprietary data management software platforms for monitoring physiological parameters, thereby aiding in prevention, diagnosis, and rehabilitation. The company was founded by Agustin Macia Barber, Luis Sanchez Morales, Rodrigo Miranda, and Jacobo Luis Crespo Criado del Rey on November 25, 2005, and is headquartered in Madrid, Spain. | Medical Specialties | Director/Board Member | |
Iden Biotechnology SL
 Iden Biotechnology SL BiotechnologyHealth Technology Iden Biotechnology SL provides biotechnological research and development services for agricultural applications. It offers applications in the production of high-yield, climate-resistant crops for food, energy, pharmaceuticals, and animal feeds. The firm also provides solutions for technology scouting, intellectual property brokering and licensing, research project management, and competitive intelligence. The company was founded by Nora Alonso on May 30, 2005 and is headquartered in Cordovilla, Spain. | Biotechnology | Chairman | |
Raman Health Technologies SL
 Raman Health Technologies SL BiotechnologyHealth Technology Raman Health Technologies SL researches and develops laser and spectroscopy-based diagnostic technology. The company was founded by Perez F. Rull on February 14, 2013 and is headquartered in Boecillo, Spain. | Biotechnology | Director/Board Member | |
| Advanced Cancer Prognostics Aie | Director/Board Member | ||
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Cross Road Biotech FCR | Miscellaneous | Chairman | |
| 3D-Shaper Medical | Director/Board Member | ||
| Additum Blockchain SL | Packaged Software | Chief Executive Officer |
Statistics
International
| Spain | 31 |
| United States | 6 |
| China | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 11 |
| Government | 4 |
| Finance | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 16 |
| Corporate Officer/Principal | 11 |
| Chief Executive Officer | 8 |
| Chairman | 5 |
| Graduate Degree | 4 |
Most connected contacts
- Stock Market
- Insiders
- José María Mato de la Paz
- Company connections
